- Home
- CMBM vs CODX Comparison
CMBM vs CODX Comparison
Compare CMBM & CODX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMBM
- CODX
- Stock Information
- Founded
- CMBM 2011
- CODX 2013
- Country
- CMBM United States
- CODX United States
- Employees
- CMBM N/A
- CODX N/A
- Industry
- CMBM Radio And Television Broadcasting And Communications Equipment
- CODX Medical/Dental Instruments
- Sector
- CMBM Technology
- CODX Health Care
- Exchange
- CMBM Nasdaq
- CODX Nasdaq
- Market Cap
- CMBM 12.1M
- CODX 11.9M
- IPO Year
- CMBM 2019
- CODX 2017
- Fundamental
- Price
- CMBM $0.45
- CODX $0.36
- Analyst Decision
- CMBM Strong Buy
- CODX Buy
- Analyst Count
- CMBM 2
- CODX 2
- Target Price
- CMBM $5.50
- CODX $5.50
- AVG Volume (30 Days)
- CMBM 140.5K
- CODX 105.9K
- Earning Date
- CMBM 05-16-2025
- CODX 05-08-2025
- Dividend Yield
- CMBM N/A
- CODX N/A
- EPS Growth
- CMBM N/A
- CODX N/A
- EPS
- CMBM N/A
- CODX N/A
- Revenue
- CMBM $172,215,000.00
- CODX $3,915,160.00
- Revenue This Year
- CMBM N/A
- CODX N/A
- Revenue Next Year
- CMBM $17.13
- CODX N/A
- P/E Ratio
- CMBM N/A
- CODX N/A
- Revenue Growth
- CMBM N/A
- CODX N/A
- 52 Week Low
- CMBM $0.23
- CODX $0.28
- 52 Week High
- CMBM $4.16
- CODX $2.23
- Technical
- Relative Strength Index (RSI)
- CMBM 47.95
- CODX 45.27
- Support Level
- CMBM $0.42
- CODX $0.34
- Resistance Level
- CMBM $0.41
- CODX $0.38
- Average True Range (ATR)
- CMBM 0.03
- CODX 0.03
- MACD
- CMBM 0.02
- CODX 0.01
- Stochastic Oscillator
- CMBM 72.70
- CODX 50.29
About CMBM Cambium Networks Corporation
Cambium Networks Corp provides wireless broadband networking infrastructure solutions for network operators, including medium-sized wireless Internet service providers, enterprises, and government agencies. The company geographically operates in North America; Europe, Middle East and Africa; Caribbean and Latin America; and Asia Pacific. It derives maximum revenue from North America.
About CODX Co-Diagnostics Inc.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.